Effect of different LDL‐apheresis methods on parameters involved in atherosclerosis
Authors:
- 1 January 2004
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 19 (2) , 90-97
Abstract
LDL‐apheresis lowers the LDL level in patients with severe hypercholesterolemia. The present study compared three apheresis methods—DSA, DALI, and plasma exchange—for effectiveness in removal of LDL and effect on various blood parameters involved in atherogenesis. The study group included 6 patients with primary hypercholesterolemia unresponsive to maximal drug therapy. All were treated first with 4 consecutive plasma exchange sessions followed by 4 DSA sessions; in four out of six, an additional 4 sessions of DALI were then performed. Levels of lipoproteins, apoproteins, CRP, homocysteine, fibrinogen, and blood count were determined before and after each session. All 3 procedures yielded a significant reduction in total cholesterol and ApoB‐containing lipoproteins, with DALI being the most effective. Also, a significant reduction in triglycerides, HDL, and ApoA1 was observed with all the methods. The reduction in HDL‐C with DSA and DALI was greater than previously reported. The LDL/HDL‐cholesterol ratio decreased significantly with DSA and DALI and increased with plasma exchange. There was a significant decrease in CRP, fibrinogen, and platelets with all three methods, and a significant decrease in homocysteine only with DSA and DALI. All three procedures effectively reduced the concentration of various compounds involved in atherosclerosis. Plasma exchange is nonselective and cannot be recommended as the procedure of choice. J. Clin. Apheresis 19:90–97, 2004.Keywords
This publication has 19 references indexed in Scilit:
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemiaAtherosclerosis, 2000
- Long-Term Effects of Low-Density Lipoprotein Apheresis Using an Automated Dextran Sulfate Cellulose Adsorption System fn1fn1This study was supported by a grant from the Kaneka America Corporation, New York, New York.The American Journal of Cardiology, 1998
- Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and OpportunitiesNew England Journal of Medicine, 1997
- LDL Hemoperfusion‐A New Procedure for LDL Apheresis: First Clinical Application of an LDL Adsorber Compatible with Human Whole BloodArtificial Organs, 1997
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997
- Different effects of two methods of low‐density lipoprotein apheresis on the coagulation and fibrinolytic systems3Journal of Internal Medicine, 1993
- The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levelsJournal of Clinical Apheresis, 1986
- Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- APPLICATION OF SPECIFIC EXTRACORPOREAL REMOVAL OF LOW DENSITY LIPOPROTEIN IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1981